位置:首页 > 蛋白库 > ZN568_MOUSE
ZN568_MOUSE
ID   ZN568_MOUSE             Reviewed;         671 AA.
AC   E9PYI1; Q0VGV0; Q3UPK4;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   03-AUG-2022, entry version 90.
DE   RecName: Full=Zinc finger protein 568 {ECO:0000312|MGI:MGI:2142347};
GN   Name=Znf568 {ECO:0000250|UniProtKB:Q3ZCX4};
GN   Synonyms=chato {ECO:0000303|PubMed:18701545, ECO:0000312|MGI:MGI:2142347},
GN   Zfp568 {ECO:0000312|MGI:MGI:2142347};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|Proteomes:UP000000589};
RN   [1] {ECO:0000312|EMBL:BAE25391.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE25391.1};
RC   TISSUE=Embryo {ECO:0000312|EMBL:BAE25391.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2] {ECO:0000312|Proteomes:UP000000589}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J {ECO:0000312|Proteomes:UP000000589};
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3] {ECO:0000312|EMBL:AAH82606.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH82606.1};
RC   TISSUE=Head {ECO:0000312|EMBL:AAH82606.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   FUNCTION, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF LEU-64.
RX   PubMed=18701545; DOI=10.1242/dev.022897;
RA   Garcia-Garcia M.J., Shibata M., Anderson K.V.;
RT   "Chato, a KRAB zinc-finger protein, regulates convergent extension in the
RT   mouse embryo.";
RL   Development 135:3053-3062(2008).
RN   [5] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH TRIM28, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LEU-64.
RX   PubMed=22110054; DOI=10.1242/dev.072546;
RA   Shibata M., Blauvelt K.E., Liem K.F. Jr., Garcia-Garcia M.J.;
RT   "TRIM28 is required by the mouse KRAB domain protein ZFP568 to control
RT   convergent extension and morphogenesis of extra-embryonic tissues.";
RL   Development 138:5333-5343(2011).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF LEU-64.
RX   PubMed=21094155; DOI=10.1016/j.ydbio.2010.11.015;
RA   Shibata M., Garcia-Garcia M.J.;
RT   "The mouse KRAB zinc-finger protein CHATO is required in embryonic-derived
RT   tissues to control yolk sac and placenta morphogenesis.";
RL   Dev. Biol. 349:331-341(2011).
RN   [7] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=23071813; DOI=10.1371/journal.pone.0047481;
RA   Chien H.C., Wang H.Y., Su Y.N., Lai K.Y., Lu L.C., Chen P.C., Tsai S.F.,
RA   Wu C.I., Hsieh W.S., Shen C.K.;
RT   "Targeted disruption in mice of a neural stem cell-maintaining, KRAB-Zn
RT   finger-encoding gene that has rapidly evolved in the human lineage.";
RL   PLoS ONE 7:E47481-E47481(2012).
RN   [8]
RP   FUNCTION, INTERACTION WITH TRIM28, MUTAGENESIS OF LYS-37; GLN-45; GLN-55;
RP   ASP-61; LEU-64; GLU-65; LEU-154 AND ASP-155, AND DOMAIN.
RX   PubMed=27658112; DOI=10.1371/journal.pone.0163555;
RA   Murphy K.E., Shylo N.A., Alexander K.A., Churchill A.J., Copperman C.,
RA   Garcia-Garcia M.J.;
RT   "The Transcriptional Repressive Activity of KRAB Zinc Finger Proteins Does
RT   Not Correlate with Their Ability to Recruit TRIM28.";
RL   PLoS ONE 11:E0163555-E0163555(2016).
RN   [9]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND DNA-BINDING.
RX   PubMed=28522536; DOI=10.1126/science.aah6895;
RA   Yang P., Wang Y., Hoang D., Tinkham M., Patel A., Sun M.A., Wolf G.,
RA   Baker M., Chien H.C., Lai K.N., Cheng X., Shen C.J., Macfarlan T.S.;
RT   "A placental growth factor is silenced in mouse embryos by the zinc finger
RT   protein ZFP568.";
RL   Science 356:757-759(2017).
CC   -!- FUNCTION: Has transcriptional repression activity, partially through
CC       the recruitment of the corepressor TRIM28 but has also repression
CC       activity independently of this interaction (PubMed:22110054,
CC       PubMed:27658112). Essential during embryonic development, where it acts
CC       as direct repressor of IGF2-P0, placental-specific transcript of IGF2,
CC       in early development and regulates convergent extension movements
CC       required for axis elongation and tissue morphogenesis in all germ
CC       layers (PubMed:18701545, PubMed:22110054, PubMed:28522536). Also
CC       important for normal morphogenesis of extraembryonic tissues including
CC       the yolk sac, extraembryonic mesoderm and placenta (PubMed:18701545,
CC       PubMed:21094155). May enhance proliferation or maintenance of neural
CC       stem cells (PubMed:23071813). {ECO:0000269|PubMed:18701545,
CC       ECO:0000269|PubMed:21094155, ECO:0000269|PubMed:22110054,
CC       ECO:0000269|PubMed:23071813, ECO:0000269|PubMed:27658112}.
CC   -!- SUBUNIT: Interacts with TRIM28. {ECO:0000269|PubMed:22110054,
CC       ECO:0000269|PubMed:27658112, ECO:0000269|PubMed:28522536}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22110054,
CC       ECO:0000269|PubMed:23071813}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=E9PYI1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=E9PYI1-2; Sequence=VSP_058610;
CC   -!- TISSUE SPECIFICITY: Little or no expression detected in most adult
CC       tissues (brain, liver, kidney, spleen, testis, ovary). In the
CC       hippocampus, detected in neural stem cells within the subventricular
CC       zone and subgranular zone. {ECO:0000269|PubMed:23071813}.
CC   -!- DEVELOPMENTAL STAGE: Expressed ubiquitously at 7.5 dpc and 8.5 dpc,
CC       with especially high levels in the extraembryonic ectoderm
CC       (PubMed:18701545). Expressed strongly in head from stages 10.5 dpc to
CC       12.5 dpc (PubMed:23071813). In fetal brain, shows highest expression
CC       levels at stage 13.5 dpc with low levels thereafter (PubMed:23071813).
CC       Detected in neural stem cells of the neocortex at stage 12.5 dpc
CC       (PubMed:23071813). {ECO:0000269|PubMed:18701545,
CC       ECO:0000269|PubMed:23071813}.
CC   -!- DOMAIN: KRAB domain 1, but not KRAB domain 2, is required for
CC       transcriptional repression. Both contribute to interaction with TRIM28.
CC       Differences in repressive activity between KRAB domain 1 and 2 are
CC       likely due to amino acid differences at multiple residues.
CC       {ECO:0000269|PubMed:27658112}.
CC   -!- DISRUPTION PHENOTYPE: Mutant embryos arrest at 9 dpc, they fail to
CC       complete gastrulation, have convergent-extension failure and a yolk sac
CC       membrane-ruffling phenotype (PubMed:28522536). Conditional knockdown in
CC       neural stem cells results in reduced brain weight at birth, however
CC       adult brain weights are normal and no other defects in brain
CC       development or morphology are apparent (PubMed:23071813). Double
CC       knockout for ZNF568 and IGF2 embryos and fetuses are found at near
CC       Mendelian ratios and indistiguishable of wild type littermates at 12.5
CC       dpc to 18.5 dpc. However, after birth few dead pups are recovered
CC       (PubMed:28522536). {ECO:0000269|PubMed:23071813,
CC       ECO:0000269|PubMed:28522536}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to competing acceptor splice
CC       site. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK143471; BAE25391.1; -; mRNA.
DR   EMBL; AC149283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC082606; AAH82606.1; -; mRNA.
DR   CCDS; CCDS21077.1; -. [E9PYI1-1]
DR   CCDS; CCDS52176.1; -. [E9PYI1-2]
DR   RefSeq; NP_001028527.2; NM_001033355.3. [E9PYI1-1]
DR   RefSeq; NP_001161344.1; NM_001167872.1. [E9PYI1-1]
DR   RefSeq; NP_001161345.1; NM_001167873.1. [E9PYI1-2]
DR   RefSeq; XP_011248871.1; XM_011250569.2. [E9PYI1-1]
DR   PDB; 5V3J; X-ray; 2.06 A; E/F=362-640.
DR   PDB; 5V3M; X-ray; 2.09 A; C=362-669.
DR   PDB; 5WJQ; X-ray; 2.79 A; D=388-668.
DR   PDBsum; 5V3J; -.
DR   PDBsum; 5V3M; -.
DR   PDBsum; 5WJQ; -.
DR   AlphaFoldDB; E9PYI1; -.
DR   SMR; E9PYI1; -.
DR   STRING; 10090.ENSMUSP00000118387; -.
DR   iPTMnet; E9PYI1; -.
DR   PhosphoSitePlus; E9PYI1; -.
DR   MaxQB; E9PYI1; -.
DR   PaxDb; E9PYI1; -.
DR   PeptideAtlas; E9PYI1; -.
DR   PRIDE; E9PYI1; -.
DR   ProteomicsDB; 302088; -. [E9PYI1-1]
DR   ProteomicsDB; 302089; -. [E9PYI1-2]
DR   Ensembl; ENSMUST00000074322; ENSMUSP00000073930; ENSMUSG00000074221. [E9PYI1-1]
DR   Ensembl; ENSMUST00000146074; ENSMUSP00000118823; ENSMUSG00000074221. [E9PYI1-2]
DR   Ensembl; ENSMUST00000148442; ENSMUSP00000118387; ENSMUSG00000074221. [E9PYI1-1]
DR   Ensembl; ENSMUST00000177931; ENSMUSP00000137438; ENSMUSG00000074221. [E9PYI1-2]
DR   GeneID; 243905; -.
DR   KEGG; mmu:243905; -.
DR   UCSC; uc009gct.2; mouse. [E9PYI1-1]
DR   UCSC; uc009gcu.2; mouse.
DR   CTD; 243905; -.
DR   MGI; MGI:2142347; Zfp568.
DR   VEuPathDB; HostDB:ENSMUSG00000074221; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000164032; -.
DR   HOGENOM; CLU_002678_44_5_1; -.
DR   InParanoid; E9PYI1; -.
DR   OMA; NREIKCH; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; E9PYI1; -.
DR   TreeFam; TF341817; -.
DR   BioGRID-ORCS; 243905; 2 hits in 75 CRISPR screens.
DR   ChiTaRS; Zfp568; mouse.
DR   PRO; PR:E9PYI1; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; E9PYI1; protein.
DR   Bgee; ENSMUSG00000074221; Expressed in placenta labyrinth and 214 other tissues.
DR   ExpressionAtlas; E9PYI1; baseline and differential.
DR   Genevisible; Q3UPK4; MM.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IMP:UniProtKB.
DR   GO; GO:0001222; F:transcription corepressor binding; IPI:UniProtKB.
DR   GO; GO:0060028; P:convergent extension involved in axis elongation; IMP:MGI.
DR   GO; GO:0022007; P:convergent extension involved in neural plate elongation; IMP:MGI.
DR   GO; GO:0060669; P:embryonic placenta morphogenesis; IMP:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0010646; P:regulation of cell communication; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07765; KRAB_A-box; 2.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 2.
DR   Pfam; PF00096; zf-C2H2; 10.
DR   SMART; SM00349; KRAB; 2.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF109640; SSF109640; 2.
DR   SUPFAM; SSF57667; SSF57667; 6.
DR   PROSITE; PS50805; KRAB; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 11.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Developmental protein; DNA-binding;
KW   Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..671
FT                   /note="Zinc finger protein 568"
FT                   /id="PRO_0000438106"
FT   DOMAIN          34..105
FT                   /note="KRAB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   DOMAIN          124..195
FT                   /note="KRAB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         363..385
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         391..413
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         419..441
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         447..469
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         475..497
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         503..525
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         531..553
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         559..581
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         587..609
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         615..637
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         643..665
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          214..366
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        16..31
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        214..246
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..345
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         106
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058610"
FT   MUTAGEN         37
FT                   /note="K->E: No effect on transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         38..39
FT                   /note="DV->AA: Strongly decreases transcriptional
FT                   repression. No effect on interaction with THRIM28. No
FT                   effect on interaction with THRIM28."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         45
FT                   /note="Q->L: No effect on transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         55
FT                   /note="Q->H: Decreases transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         61
FT                   /note="D->A: Decreases transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         64
FT                   /note="L->P: In chato; probable null mutation. Almost
FT                   abolishes transcriptional repression. No effect on
FT                   interaction with THRIM28. Embryonic development arrests at
FT                   stage 9 dpc. Widespread morphogenetic defects are found in
FT                   all germ layers, associated with defective convergent
FT                   extension movements. The anterior-posterior axis is
FT                   abnormally shortened, somites are mediolaterally expanded,
FT                   and the neural tube fails to close normally. Morphogenesis
FT                   of most mesodermal tissues is also defective. The
FT                   definitive endoderm fails to narrow and elongate leading to
FT                   an open gut tube. Extraembryonic tissues are also abnormal
FT                   with bubble-like protrusions in the yolk sac, aberrant
FT                   migration of extraembryonic mesoderm, and incomplete
FT                   placental development. Abolishes interaction with TRIM28;
FT                   when associated with P-154."
FT                   /evidence="ECO:0000269|PubMed:18701545,
FT                   ECO:0000269|PubMed:21094155, ECO:0000269|PubMed:22110054,
FT                   ECO:0000269|PubMed:27658112"
FT   MUTAGEN         65
FT                   /note="E->D: Decreases transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         128..129
FT                   /note="DV->AA: No effect on transcriptional repression. No
FT                   effect on interaction with THRIM28."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         154
FT                   /note="L->P: No effect on transcriptional repression.
FT                   Abolishes interaction with TRIM28; when associated with P-
FT                   64."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   MUTAGEN         155
FT                   /note="D->E: Increases transcriptional repression. No
FT                   effect on interaction with THRIM28."
FT                   /evidence="ECO:0000269|PubMed:27658112"
FT   CONFLICT        569
FT                   /note="T -> S (in Ref. 1; BAE25391)"
FT                   /evidence="ECO:0000305"
FT   STRAND          366..368
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           375..387
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          399..402
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           403..410
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           411..413
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          414..416
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            422..424
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          427..430
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           431..442
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            450..452
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          455..458
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           459..466
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:5WJQ"
FT   STRAND          478..481
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          483..486
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           487..498
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            506..508
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          511..514
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           515..521
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           523..526
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            534..536
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          539..542
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           543..554
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            562..564
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          567..570
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           571..582
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            590..592
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          595..598
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           599..610
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            618..620
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   STRAND          623..626
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   HELIX           627..637
FT                   /evidence="ECO:0007829|PDB:5V3J"
FT   TURN            646..648
FT                   /evidence="ECO:0007829|PDB:5WJQ"
FT   HELIX           655..662
FT                   /evidence="ECO:0007829|PDB:5WJQ"
FT   TURN            663..665
FT                   /evidence="ECO:0007829|PDB:5WJQ"
SQ   SEQUENCE   671 AA;  77116 MW;  7131EA8702CE490E CRC64;
     MERLSQMAGR RAWCAEDSVP RQEEEDRTRP SKTVTFKDVA VDLTQEEWQQ MKPAQRALYR
     DVMLETYSNL VTVGCQVTKP DVIFKLEQAE EPWVLEEEMF WRRSPEAARG RMKSFAFKDM
     AKDLRFEDVV IYFSLEEWEC LRHSHRNLYR AVMLDNYSNL LSLSLADTKP RVVSLLEQGK
     EPWMVMRNET KIWHPDWVSR TEAKDSSKIK TLQEKMAKKH TCPTLEDSKT RGDREVTREL
     EGQQVHQEGH LRQAAVTSVE RPDSVQCTAH REAHPGGKPC SSEKSQKTSL CQPPPIEREQ
     LHSKAKASEH AQHGKVFNSC TSDTAVHPRP QESRKDSERK KSALAGGPDT SKPQSAQGSE
     RPHKCKECGK AFHTPSQLSH HQKLHVGEKP YKCQECGKAF PSNAQLSLHH RVHTDEKCFE
     CKECGKAFMR PSHLLRHQRI HTGEKPHKCK ECGKAFRYDT QLSLHLLTHA GARRFECKDC
     DKVYSCASQL ALHQMSHTGE KPHKCKECGK GFISDSHLLR HQSVHTGETP YKCKECGKGF
     RRGSELARHQ RAHSGDKPYK CKECGKSFTC TTELFRHQKV HTGDRPHKCK ECGKAFIRRS
     ELTHHERSHS GEKPYECKEC GKTFGRGSEL SRHQKIHTGE KPYKCQQCGK AFIRGSHLTQ
     HQRIHTGRRS E
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024